CELLIVERY THERAPEUTICS
Cellivery’s therapeutic drug candidates are being developed for the prevention of life-threatening lethal diseases, including various cancer. The company’s subsequent drug discovery programs will focus on other diseases, in which the transient suppression of either symptoms or etiology would produce long-term benefits, that are both cost-effective and associated with a high quality of life. Cellivery Therapeutics Inc. was founded by Dr. Daewoong Jo, President and CEO in March of 2014. Its earliest notions have been prepared, however, when Dr. Jo began to study for his doctoral thesis at Vanderbilt University, Nashville, TN, USA in 1997.
CELLIVERY THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-03-06
Address:
Mapo, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.cellivery.com
Total Employee:
101+
Status:
Active
Contact:
+82-2-6495-7866~7
Technology used in webpage:
SPF Nginx Korea Telecom Cafe24 DNS
Similar Organizations
Avammune Therapeutics
Avammune Therapeutics is a drug discovery company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Onspira Therapeutics
Onspira Therapeutics operates as a clinical-stage biopharmaceutical company.
SIRS Therapeutics
SIRS Therapeutics operates as a therapeutics company.
Founder
Stock Details
Official Site Inspections
http://www.cellivery.com Semrush global rank: 3 M Semrush visits lastest month: 5.41 K
- Host name: 203.245.24.33
- IP address: 203.245.24.33
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
